Business Standard

Saturday, December 21, 2024 | 10:30 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Vaccine policy group seeks more lab data on tests for mixing Covid doses

NTAGI has a month to go before it gives its advice to the government on inoculation strategy.

vaccine
Premium

Sohini Das Mumbai
The organisation that makes India’s vaccination strategy has sought more laboratory data before it decides on advising mixing Covid-19 doses—a medical practice called heterologous boosting.

The National Technical Advisory Group on Immunisation (NTAGI) has month to go before its gives its advice to the government. It has sought more laboratory data from the Christian Medical College (CMC), Vellore, where researchers are conducting a study on mixing Covid-19 vaccines, said sources in the know.

CMC will conduct more tests on neutralising antibodies on 400 subjects enrolled for a study on testing how mixing Covaxin (a vaccine manufactured by Bharat Biotech) and Covishield (manufactured

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in